The autoimmune disease diagnostics market can be segmented based on applications such as systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics.This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Sourced through from: www.transparencymarketresearch.com

Autoimmune disease refers to a medical disorder characterized by inflammatory reactions caused by the overactive immune response of the body resulting in the actions against own cells and body tissues. There are more than 80 types of autoimmune diseases and are known to be more prevalent in women than men. According to the National Institute of Health (NIH), autoimmune diseases are ranked amongst the top ten causes of death in women in the U.S. Autoimmune disease diagnostics include the procedures that assist in identification of disease type and stage. Symptoms associated with autoimmune diseases include inflammation, fatigue, fever, joint pain, and rashes. Inflammation can further lead to redness, heat, pain, and swelling of the affected body part. The increasing prevalence of autoimmune diseases, growing public awareness and supportive government policies are the major factors driving the global autoimmune disease diagnostics market. Improved laboratory techniques and advancements in the healthcare sector is also expected to fuel the market growth. However, low prevalence of localized autoimmune diseases as compared to systemic diseases and increasing rate of diagnostic errors are restraining the growth of autoimmune disease diagnostics market.

Browse Full Report with TOC @ http://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html

The autoimmune disease diagnostics market can be segmented based on applications such as systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. Systemic autoimmune disease diagnostics can be further categorized into rheumatoid arthritis diagnostic, ankylosing spondylitis diagnostics, and systemic lupus erythematosus. The product market based on technologies currently used for autoimmune disease diagnostics include indirect immunofluorescence (IIF-ANA), enzyme-linked immunoabsorbent assay (ELISA), western blot technique, dot blot technique, line blot technique, multiplex immunoassays and others (agglutination, double immune diffusion, and counterimmunoelectrophoresis). The analysis of autoantibodies (autoimmune disease) by immunofluorescence remains the hallmark of diagnosis but is being replaced by enzyme immunoassays (ELISA) and multiplexed assays due to its high disease specificity and efficiency.

Geographically, North America dominates the global autoimmune disease diagnostics market, followed by Europe. High prevalence, well developed medical infrastructure, government initiatives and increasing investments on R&D in these regions are the major drivers responsible for the market growth. A boost is expected in the U.S. autoimmune market due to implementation of the Patient Protection and Affordable Care Act (PPACA). In Europe, autoimmune disease diagnostics market has shown significant growth due to high prevalence of autoimmune diseases. Developed countries of Europe have projected high prevalence rate compared to other regions of the autoimmune disease diagnostics. The prevalence pattern in Europe is similar to North America i.e. women are more prone to cause autoimmune disease than men. China and India are expected to be the fastest growing markets in the next five years. The rising population, increasing awareness regarding better health care facilities, and improving health care infrastructure are the major drivers of autoimmune disease diagnostic market. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, high disposable income and rising prevalence of autoimmune diseases.

Some of the major companies operating in autoimmune disease diagnostic market are Abbott Laboratories Ltd, Active Biotech, AstraZeneca plc, Amgen, Inc., Eli Lilly and Company, 4SC AG, Bristol-Myers Squibb Company, Pfizer, Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Johnson & Johnson Ltd.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5351

Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm

Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm

Contact Us

Mr. Nachiket Ghumare
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

See on – alina martin

Healthcare information exchange (HIE) is an integral part of health information technology (HIT) infrastructure. HIE refers to the mobilization of healthcare information electronically within defined geographical area to bring healthcare stakeholder together.

Sourced through from: www.transparencymarketresearch.com

Healthcare information exchange (HIE) is an integral part of health information technology (HIT) infrastructure. HIE refers to the mobilization of healthcare information electronically within defined geographical area to bring healthcare stakeholder together.Stakeholder includes pateints, doctors, nurses, pharmacists, labs, and other health care providers. According to the study conducted at Sushoo Health Information Exchange, present method of exchanging patient information incurs cost of approximately USD 17,160 annually for single clinician practice. Henceforth, creates a demand foreffective electronic storage and exchange of patient information system. Thus, HIE facilitatesspeedy access and sharingof patients clinical data to the healthcare providersfor providing timely, effective and efficient delivery of care to the patient. Timely sharing of patient information helps in effective decision making the time of point of care, avoids readmissions, medication erros, decreases duplicate testing and improve diagnosis rate. HIE consists of clinical data from providers, activity and cost data from payers and providers, and public health data. The technology provides high standard of patient care along with reduced expenses associated with manual printing of document, physical mailing of patient records, time and efforts involved in recovering patient reports. However, structure and geographical scope of HIEs may vary across the country. Some may serve to small geographic region, some across the state or some may serve to the multistate region.

Browse Full Report with TOC @ http://www.transparencymarketresearch.com/healthcare-information-exchange-market.html

Need for greater access to patient health information, rising awareness of HIE technology, enhanced stakeholders collaborations are some of the major drivers for health information exchange market. Additionally, increasing U.S. government incentive program and high cost associated with health information exchange current system are other factorsanticipated to propel the growth of HIE industry. However, complex technology, high initial investment, and less return on investment are major restrain of the market.

The HIE market can be categorized based on the set up type, by implementation model and by vendors type. On the basis of set up type market can be further segmented into private HIE and public HIE. Furthermore, based on implementation type market could be classified into centralized model, decentralized model, and hybrid model. By considering vendor’s type market of health information exchange can be further segmented into platform centric, messaging centric, portal centric, and others such as personal health records (PHR) and clinical data management (CDM). Geographically, HIE market is categorized into North America, Europe, Asia Pacific, Latin America and RoW.

Among the implementation type, hybrid model is considered as a potential market segment as it is a combination of both centralized and decentralized model hence offers advantages associated with both of the above mentioned types.In set up typesegment private health information exchange market dominates the market due to their clear business model,physician engagement at every level of HIE, and steady flow of funds for development. Portal centric segment is currently the largest market share holder of health information exchange in vendor types and is anticipated to grow further at a substantial growth rate in the near future. Geographically in 2013, largest share of the market was accounted by North America, due to presence of majority of companies in the U.S. however, Asia Pacific is expected to grow at a higher rate due to increasing awareness about HIE, rising population base and various initiatives being undertaken by the governments in countries such as India, China, Japan and South Korea.

Some of the major players in the healthcare information exchange market includes AT&T, Inc., GE Healthcare, IBM Corporation, InterSystems Corporation, Medicity, Siemens AG, CareEvolution Inc., Cerner Corporation, and Orion Health.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Healthcare IT Market: http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5339

Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm

Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm

Contact Us

Mr. Nachiket Ghumare
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

See on – alina martin

Global investment in nanotechnology research has witnessed a six fold increase during the last decade.This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Sourced through from: www.transparencymarketresearch.com

Nanocapsules are drug delivery agents within the size range of 10nm to 1000 nm that are normally composed of a capsule shell and a hollow space in which desired substance or drug molecules are embedded. The ultrafine size of nanocapsules match the biological composition of human body such as RBCs which permits enhanced permeation and retention (EPR) through narrow channels during diffusion. Due to this EPR effect, nanocapsules are used as drug carriers. Nanocapsules can be formulation using various methods such as loading of drug molecules into hollow polyelectrolyte shell and another method being electrostatic layer by layer (LbL) technique. These latest LbL self-assembled polyelectrolyte capsules provide an efficient way to perform multiple drug delivery tasks simultaneously. Some nanocapsules are used for targeted drug delivery in anti-tumor and anti-tuberculosis therapies wherein the outer sphere of nanocapsules is fabricated by the lithography technique. Lipid nanocapsules (DNA LNCs) and multimodular systems (DNA MMS) are used in gene therapy.

Browse Full Report with TOC @ http://www.transparencymarketresearch.com/nanocapsules-market.html

Global investment in nanotechnology research has witnessed a six fold increase during the last decade. Consequently, nanotechnology will completely revolutionize the industrial processes in the near future due to its remarkable economic potential. Some of the key drivers for the market growth include investments and breakthroughs in biomedical, pharmaceutical, electronics, molecular and diagnostic fields. Besides, these nanocapsules are being increasingly used in agrochemicals, environment and wastewater treatments, genetic engineering, consumer goods and cosmetic procedures. Some of the most advanced future applications would be nanocapsule dressings to deliver antibiotics aiding faster wound healing without invasion to the skin. These nanocapsule bandages would be consistently demanded by defence and protection forces as they need not be changed periodically. According to the experts, electronics and magnetic sector will be the largest potential market for nanocapsules, followed by biopharmaceutical industry, catalysis, energy and engineering. However, growth in the nanocapsules market will also pose new challenges with respect to the toxicity and environmental impact of nanocapsules. Recently efforts have been made to overcome these drawbacks by developing eco-friendly versatile nanocapsules. For instance, nanocapsules introduced by the Center for Self-assembly and Complexity, Institute for Basic Science (IBS). Other factors such as cost escalation and consequences on the global economy especially in cases of under-developed economies with poor R&D investment would exhibit low social and ethical acceptance of nanocapsules.

Funding for nanotechnology is soaring worldwide at a competitive level, with each major economic power and many developed economies making a substantial investment to revamp their industrial and postindustrial supply chains. Technological inventions and discoveries in nanotechnology would cause tremendous growth in the global nanocapsule market. Due to a variety of potential applications, nanotechnology is expected to become the key technology in the near future. U.S. has invested around USD 3.7 billion through its National Nanotechnology Initiative for research activities. The European Union had spent approximately USD 1.2 billion and Japan USD 750 million by 2012. Moreover, there is a steady demand for medically advanced procedures in developed as well as developing regions having a well-established healthcare infrastructure. In the Asia Pacific region, the demand for nanocapsules is projected to rise owing to the high disease burden of tuberculosis and cancer. Some of the key factors that are likely to contribute toward the market growth are growing awareness about genetic counselling, genetic disorders, high prevalence of tuberculosis and multi-drug resistant tuberculosis, increasing trend in cancer and tumor ailments and surging demand for oncological treatments.

Presently, nanocapsules are under different stages of clinical trial phases facing several hurdles to gain market entry. However, few commercially available nanocapsules which are now commercially used as several pigments in sunscreen, scratch resistance coatings, catalysts, and biomarkers. Some of the key market players for these commercially available nanocapsules are Abraxis, Artificial Cell Technologies, Inc., BioDelivery Sciences International, Inc., Biophan Technologies, Inc., Cornerstone Pharmaceuticals, Inc., Genetic Immunity, Inc., Keystone Nano, Inc., Makefield Therapeutics, Inc., Nanospectra Biosciences, Inc., and Mersana Therapeutics, Inc.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5321

Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm

Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm

Contact Us

Mr. Nachiket Ghumare
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

 

See on – alina martin

The U.S. has the largest health care system in the world and one of the biggest health insurances market.This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Sourced through Scoop.it from: www.transparencymarketresearch.com

The concept of health insurance, in general, is objectively simple whereinan individual or organization purchase services or plans to avoid their risk in event of un-avoidable health conditions. Health insurance provides financial security to the people in their health care needs. The health insurance industry is one of the cardinal componentsof the global economy by virtue of the amount of revenue it collects, the extent of the global investment, and most prominently the indispensablesocio-economic role it plays by securing personal and business risk in the event of an unforeseen problems.

Browse Full Report with TOC @ http://www.transparencymarketresearch.com/health-insurance-market.html

In 2014, the macro-economic condition across the globedemonstratedsubstantial improvement, with disposable income and GDP per capita rising in many countries and both the high income group and middle class increasing in number and financial resources. These aspectsaugur well for the globalhealth insurancecorporations such as United Health Group. Many payers (insurance companies) and investment firms are investing in digitalization of business process that strengthen their affiliations with customers across all geographies and product classifications. Many of the companies such as Cigna Corp. empower both consumers and its own resources to better shop for insurance, easier to understand and compare, and making products more transparent. Furthermore, insurance companies are exploiting on cloud computing, data analytics, and modeling techniques to improve their market penetration strategies, strengthen risk management and decrease claims fraud. Some of the companies are also investing in technology solutions to optimize business processes, regulatory compliance and increase alliance across the organizations. The key issues in healthcare insurance industry or rather more specific to insurance providers include rising competition, generally soft pricing conditions and tight profit margins. Moreover, the economic turbulence in 2008 has affected employer and corporate health insurance business in the developed countries to some extent due to cost cutting and lay-off of employees and slowdown of new recruitments. However, at individual levels,the market has not shown any significant slowdown.

The U.S. has the largest health care system in the world and one of the biggest health insurances market. The U.S. health insurance market is consolidated by few major players which covers more than 80% of private and public (Medicare and Medicaid) managed insurance. The country’s largest health care provides include UnitedHealth Group Inc., Anthem Inc., Aetna Inc., Cigna Corp., and Humana Inc. The cardinal challenges for existing company or especially from new capital entrants in the U.S. health insurance market include immense competition and rising customer expectations. Success in this environment would be enhanced by expanding digital capabilities, empowerment of customers and distributors with self-service features and making insurance products easier to understand, compare and purchase. European health insurance market especially in EU5 countries (U.K., Germany, France, Italy, and Spain) is quite stable owing to significant contribution from government. The growth prospective for the private players is limited due to universal health coverage plans in these countries.

Furthermore, the rest of Europe health insurance market for private players continue to challenge as economic recovery throughout the region is overshadowed by low business investment rates, and slower industry growth. In Asia Pacific, the growth prospects remain high due to increasing GDP, rise in disposable income, and growing trend toward health security. Furthermore, the growth of the middle class and high net worth population in Asia Pacific presents an immense opportunity for international players to exploit the emerging market.

Some of the key players in global health insurance market include UnitedHealth Group Inc.,Allianz SE, AIA Insurance Group, Express Scripts Holding Company, Zurich Insurance Group Ltd., AXA, Aviva plc, Aetna, Inc., International Medical Group, Apollo Munich Health Insurance, and Cigna Corporation.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

Market growth drivers Factors limiting market growthCurrent market trends Market structureMarket projections for upcoming years.

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Healthcare IT Market:

http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying:

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5312

Latest Press Release Reports:

http://www.transparencymarketresearch.com/press-releases.htm

Latest Articles Reports:

http://www.transparencymarketresearch.com/articles.htm

Contact Us

Mr. Nachiket Ghumare
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

See on Scoop.italina martin

Healthcare analytics is an evidence-based strategy for data collection from multiple sources and its analysis which indicate certain trends and patterns for efficient and improvised healthcare interventions. The term has been widely used for drawing inferences from factual data which has been quantified through analytical procedures. The analytical techniques can be classified into predictive (identifying trends from simulation and modelling techniques), prescriptive (optimal and efficient clinical and financial outcomes), and descriptive(describing current situation through standard reporting) techniques. The digitization of the clinical data that are available in a variety of forms/clinical records such as images, lab results, and reports, administrative and financial informationwill aid in the paperless repository of healthcare intelligence. This revolution will improve the efficiency,accuracy and service delivery of the health systemswith improved clinical outcomes and patient care along with reduced hospital readmissions& healthcare costs.

Browse Full Report with TOC @ http://www.transparencymarketresearch.com/healthcare-analytics-market.html

Healthcare analytics has become a silver bullet targeting a multitude of issues and challenges cropping in the current scenario where resource crunches, regulatory pressures on healthcare providers & health insurance companies, disease surveillance and identification of population at risk amidst global pandemics Besides, operational advantages to the healthcare industry in terms of revenue management cycle, and consolidation of the health records; there are several other domains where healthcare analytics can be used extensively . Healthcare analytics can be an effective tool for stratifying population to cater to public health priorities on epidemiological basis. It can be of immense value in national preventive care, empowering patients with rights, health policy recommendation, public health financing, efficient government spending in health infrastructure, and facilitate enforcement of healthcare laws for patient protection in developing countries.

The technological and cultural barriers at the data source point, data breach or security issues, issues with confidentiality of the information, and lack of skilled personnel may restrain the growth of this industry across the globe. Moreover, associated break points in creating global healthcare analytics network due to fragmented international political and economic relations may also pose a major threat towards the healthcare analytics market. Geographically, North America dominates the healthcare analytics market, which is evident from the presence of key market players in the United States. Moreover, the large market share is attributable to the impact of legislations in the U.S such as Electronic Health Records (EHR), and incentives funded by the Health Information Technology for Economic and Clinical Health (HITECH). It will further gain importance when hospital readmissions will be penalized by the U.S Centers for Medicare and Medicaid.

The healthcare analytics market can be segmented by end-users such as healthcare providers, public health systems, private healthcare providers, monitoring agencies/Accountable care Organizations (ACOs)/federal regulations, health insurance companies, clinical and medical research bodies/ CROs, technology vendors. By major application areas, the healthcare analytics market can be segmented into Big Data analytics, HIPAA, predictive analytics, genome sequencing and genome wide association studies in the Electronic Medical Records and Genomics (eMERGE) network.

Majority of the healthcare organizations place high value to the analytic elements like data visualization, historic trend analysis, standardized reporting, forecasting, simulations and scenario development. There is a growing demand for scalability both in terms of technology and human resources with specialized expertise and skills. Some of the leading market players in the healthcare analytics market include Cognizant, Health Catalyst, IBM, Mede Analytics, Inc., MedAssets, Inc., McKesson Corporation, Optum,Oracle, Inc., SAS Inc., Truven Health Analytics, and Verisk Health.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Healthcare IT Market: http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5309

Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm

Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm

Contact Us

Mr. Nachiket Ghumare
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com